The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

被引：0
|
作者：
Adam M Deane
Marianne J Chapman
Robert JL Fraser
Carly M Burgstad
Laura K Besanko
Michael Horowitz
机构：
[1] University of Adelaide,, Discipline of Anaesthesia and Intensive Care
[2] Royal Adelaide Hospital,Department of Intensive Care
[3] Repatriation General Hospital,Investigation and Procedures Unit
[4] University of Adelaide,Discipline of Medicine
[5] Royal Adelaide Hospital,Department of Gastroenterology
来源：
Critical Care | / 13卷
关键词：
Glucagon; Enteral Feeding; Glucagon Concentration; Glycaemic Response; Royal Adelaide Hospital;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Effect on Cardiac Function of Exercise Combined with Glucagon-like Peptide-1 Receptor Agonist Treatment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Jorgensen, Peter G.
    Jensen, Magnus T.
    Mensberg, Pernille
    Storgaard, Heidi
    Nyby, Signe
    Jensen, Jan S.
    Kiens, Bente
    Richter, Erik A.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES, 2016, 65 : A266 - A266
  • [12] Glucagon-Like Peptide-1 Infusion Suppresses Aldosterone Levels in Healthy Normal-Weight Individuals: Double-Blind, Placebo-Controlled Crossover Study
    Maja Baretić
    Vesna Kušec
    Ivana Pavlić-Renar
    Diabetes Therapy, 2018, 9 : 2315 - 2324
  • [13] Glucagon-Like Peptide-1 Infusion Suppresses Aldosterone Levels in Healthy Normal-Weight Individuals: Double-Blind, Placebo-Controlled Crossover Study
    Baretic, Maja
    Kusec, Vesna
    Pavlic-Renar, Ivana
    DIABETES THERAPY, 2018, 9 (06) : 2315 - 2324
  • [14] Intervention with a glucagon-like peptide-1 receptor agonist improves glycaemic control in women with prior gestational diabetes: a randomised, placebo-controlled trial
    Foghsgaard, S.
    Vedtofte, L.
    Bahne, E.
    Andreasen, C.
    Mathiesen, E. R.
    Svare, J. A.
    Christiansen, L. K.
    Holst, J. J.
    Clausen, T. D.
    Damm, P.
    Knop, F. K.
    Vilsboll, T.
    DIABETOLOGIA, 2016, 59 : S386 - S386
  • [15] The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
    Lee, Michael Y.
    Fraser, Jonathan D.
    Chapman, Marianne J.
    Sundararajan, Krishnaswamy
    Umapathysivam, Mahesh M.
    Summers, Matthew J.
    Zaknic, Antony V.
    Rayner, Christopher K.
    Meier, Juris J.
    Horowitz, Michael
    Deane, Adam M.
    DIABETES CARE, 2013, 36 (10) : 3333 - 3336
  • [16] Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
    Jorsal, Anders
    Kistorp, Caroline
    Holmager, Pernille
    Tougaard, Rasmus Stilling
    Nielsen, Roni
    Hanselmann, Anja
    Nilsson, Brian
    Moller, Jacob Eifer
    Hjort, Jakob
    Rasmussen, Jon
    Boesgaard, Trine Wellov
    Schou, Morten
    Videbaek, Lars
    Gustafsson, Ida
    Flyvbjerg, Allan
    Wiggers, Henrik
    Tarnow, Lise
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (01) : 69 - 77
  • [17] Is Double-Blinding Achievable in Placebo-Controlled Trials with the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide?
    Foghsgaard, Signe
    Vedtofte, Louise
    Bahne, Emilie
    Andreasen, Camilla
    Christiansen, Liselotte K.
    Clausen, Tine D.
    Svare, Jens A.
    Mathiesen, Elisabeth R.
    Damm, Peter
    Gluud, Lise L.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES, 2017, 66 : A302 - A303
  • [18] Effect on cardiac function of exercise combined with glucagon-like peptide-I receptor agonist treatment: a randomised double-blind placebo-controlled clinical trial
    Jorgensen, P. G.
    Jensen, M. T.
    Mensberg, P.
    Storgaard, H.
    Nyby, S.
    Jensen, J. S.
    Kiens, B.
    Richter, E. A.
    Knop, F. K.
    Vilsboll, T.
    DIABETOLOGIA, 2016, 59 : S368 - S369
  • [19] Glucagon-like peptide 1 is a key factor in early and late dumping syndrome after gastrectomy: a randomised, double-blind, placebo controlled crossover study
    Roberts, Geoffrey
    Reimann, Frank
    Gribble, Fiona
    Hardwick, Richard
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 6 - 7
  • [20] GLUCAGON-LIKE PEPTIDE-1 AFFECTS TASTE PERCEPTION DIFFERENTLY IN WOMEN: A RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER STUDY
    Baretic, Maja
    Kusec, Vesna
    Uroic, Valentina
    Pavlic-Renar, Ivana
    Altabas, Velimir
    ACTA CLINICA CROATICA, 2019, 58 (02) : 240 - 248
12345